Literature DB >> 16790802

Toxoplasma gondii inhibits toll-like receptor 4 ligand-induced mobilization of intracellular tumor necrosis factor alpha to the surface of mouse peritoneal neutrophils.

Soumaya Bennouna1, Woraporn Sukhumavasi, Eric Y Denkers.   

Abstract

Neutrophils are well-known to rapidly respond to infection through chemotactic infiltration at sites of inflammation, followed by rapid release of microbicidal molecules, chemokines, and proinflammatory cytokines. For tumor necrosis factor alpha (TNF-alpha), we recently found that neutrophils contain intracellular pools of the cytokine and display the capacity to upregulate transcriptional activity of the gene during lipopolysaccharide (LPS) stimulation. We now show that triggering of mouse peritoneal neutrophils with Toll-like receptor 2 (TLR2), TLR4, and TLR9 ligands, but not ligands of TLR3, induces upregulation of surface membrane TNF-alpha. However, neutrophils infected with the protozoan Toxoplasma gondii displayed an inability to respond fully in terms of TLR ligand-induced increases in membrane TNF-alpha expression. Infected neutrophils failed to display decreased levels of intracellular TNF-alpha upon LPS exposure. In contrast to intermediate inhibitory effects in nontreated neutrophils, T. gondii induced a complete blockade in LPS-induced surface TNF-alpha expression in the presence of the protein synthesis inhibitor cycloheximide. Despite these inhibitory effects, the parasite did not affect LPS-induced upregulation of TNF-alpha gene transcription. Collectively, the results show that Toxoplasma prevents TLR ligand-triggered mobilization of TNF-alpha to the neutrophil surface, revealing a novel immunosuppressive activity of the parasite.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16790802      PMCID: PMC1489702          DOI: 10.1128/IAI.01573-05

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  39 in total

Review 1.  In the belly of the beast: subversion of macrophage proinflammatory signalling cascades during Toxoplasma gondii infection.

Authors:  Eric Y Denkers; Leesun Kim; Barbara A Butcher
Journal:  Cell Microbiol       Date:  2003-02       Impact factor: 3.715

2.  Cross-talk in the innate immune system: neutrophils instruct recruitment and activation of dendritic cells during microbial infection.

Authors:  Soumaya Bennouna; Susan K Bliss; Tyler J Curiel; Eric Y Denkers
Journal:  J Immunol       Date:  2003-12-01       Impact factor: 5.422

Review 3.  Neutrophil production of IL-12 and other cytokines during microbial infection.

Authors:  Eric Y Denkers; Laura Del Rio; Soumaya Bennouna
Journal:  Chem Immunol Allergy       Date:  2003

4.  Killing activity of neutrophils is mediated through activation of proteases by K+ flux.

Authors:  Emer P Reeves; Hui Lu; Hugues Lortat Jacobs; Carlo G M Messina; Steve Bolsover; Giorgio Gabella; Eric O Potma; Alice Warley; Jürgen Roes; Anthony W Segal
Journal:  Nature       Date:  2002-03-21       Impact factor: 49.962

Review 5.  Tumor necrosis factor-alpha converting enzyme.

Authors:  Roy A Black
Journal:  Int J Biochem Cell Biol       Date:  2002-01       Impact factor: 5.085

6.  Membrane-bound TNF supports secondary lymphoid organ structure but is subservient to secreted TNF in driving autoimmune inflammation.

Authors:  S R Ruuls; R M Hoek; V N Ngo; T McNeil; L A Lucian; M J Janatpour; H Körner; H Scheerens; E M Hessel; J G Cyster; L M McEvoy; J D Sedgwick
Journal:  Immunity       Date:  2001-10       Impact factor: 31.745

7.  Toxoplasma gondii interferes with lipopolysaccharide-induced mitogen-activated protein kinase activation by mechanisms distinct from endotoxin tolerance.

Authors:  Leesun Kim; Barbara A Butcher; Eric Y Denkers
Journal:  J Immunol       Date:  2004-03-01       Impact factor: 5.422

8.  TLR9 signals after translocating from the ER to CpG DNA in the lysosome.

Authors:  Eicke Latz; Annett Schoenemeyer; Alberto Visintin; Katherine A Fitzgerald; Brian G Monks; Cathrine F Knetter; Egil Lien; Nadra J Nilsen; Terje Espevik; Douglas T Golenbock
Journal:  Nat Immunol       Date:  2004-01-11       Impact factor: 25.606

Review 9.  Toxoplasma gondii: transmission, diagnosis and prevention.

Authors:  D Hill; J P Dubey
Journal:  Clin Microbiol Infect       Date:  2002-10       Impact factor: 8.067

10.  Both lymphotoxin-alpha and TNF are crucial for control of Toxoplasma gondii in the central nervous system.

Authors:  Dirk Schlüter; Lai-Yu Kwok; Sonja Lütjen; Sabine Soltek; Sigrid Hoffmann; Heinrich Körner; Martina Deckert
Journal:  J Immunol       Date:  2003-06-15       Impact factor: 5.422

View more
  6 in total

Review 1.  Toll-like receptors and leishmaniasis.

Authors:  Felipe F Tuon; Valdir S Amato; Hélio A Bacha; Tariq Almusawi; Maria I Duarte; Vicente Amato Neto
Journal:  Infect Immun       Date:  2007-12-10       Impact factor: 3.441

2.  CCL3 and viral chemokine-binding protein gg modulate pulmonary inflammation and virus replication during equine herpesvirus 1 infection.

Authors:  Gerlinde R Van de Walle; Kaori Sakamoto; Nikolaus Osterrieder
Journal:  J Virol       Date:  2007-12-12       Impact factor: 5.103

3.  Sex bias in susceptibility to MCMV infection: implication of TLR9.

Authors:  Stephanie Traub; Olivier Demaria; Lionel Chasson; Fabienne Serra; Benoit Desnues; Lena Alexopoulou
Journal:  PLoS One       Date:  2012-09-20       Impact factor: 3.240

4.  Host cell signalling and leishmania mechanisms of evasion.

Authors:  Marina Tiemi Shio; Kasra Hassani; Amandine Isnard; Benjamin Ralph; Irazu Contreras; Maria Adelaida Gomez; Issa Abu-Dayyeh; Martin Olivier
Journal:  J Trop Med       Date:  2011-11-03

5.  Possible role of TLR4 and TLR9 SNPs in protection against congenital toxoplasmosis.

Authors:  W Wujcicka; Z Gaj; J Wilczyński; D Nowakowska
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-08-09       Impact factor: 3.267

6.  Contributions of HLA haplotypes, IL8 level and Toxoplasma gondii infection in defining celiac disease's phenotypes.

Authors:  Mohammad Rostami-Nejad; Seyed Hossein Hejazi; Amado Salvador Peña; Hamid Asadzadeh-Aghdaei; Kamran Rostami; Umberto Volta; Mohammad Reza Zali
Journal:  BMC Gastroenterol       Date:  2018-05-18       Impact factor: 3.067

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.